Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress

Maria Marchetti, Lionel Resnick, Edna Gamliel et al. · 2009

Read Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress by Maria Marchetti, Lionel Resnick, Edna Gamliel et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005804.txt.

Description

Maria Marchetti and co-authors reported in 2009 that a common anti-inflammatory drug makes cancer cells easier to kill under oxidative stress. Sulindac, an approved NSAID, blocks enzymes that make prostaglandins. It has long drawn interest for preventing colon polyps and cancer.

Under stress from reactive oxygen, sulindac-treated cancer cells died more readily in the team's work. That pairing could matter for therapy: stress the cell, then remove its shield. The drug's long safety record makes such ideas quicker to test in people. The study adds a mechanism to an old drug's anticancer reputation.

Catalog record

CREATORMaria Marchetti, Lionel Resnick, Edna Gamliel et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005804

Browse the full library · About the Tower of Babel